Nuwellis swings to Q3 2026 net loss of $1.97 million from year-earlier profit

• Nuwellis swung to a third-quarter 2026 net loss of $1.97 million from year-earlier net income of $468,000.
• Operating loss narrowed 24% year over year to $2.05 million, while operating expenses fell 13% to $3.59 million.
• Net sales declined year over year to $2.21 million but rose 12% from the second quarter of 2026.
• Aquadex console sales climbed 88% year over year to 32 units in the first nine months of 2026.
• The company sought FDA clearance to expand Aquadex use to pediatric patients weighing at least five kilograms and secured two distribution agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611120800PRIMZONEFULLFEED9875894) on November 12, 2026, and is solely responsible for the information contained therein.